Fred Alger Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76M | Buy |
+88,198
| New | +$2.76M | 0.01% | 293 |
|
|
2021
Q3 | – | Sell |
-72,209
| Closed | -$2.8M | – | 559 |
|
|
2021
Q2 | $2.8M | Sell |
72,209
-3,094
| -4% | -$120K | 0.01% | 335 |
|
|
2021
Q1 | $3.63M | Sell |
75,303
-11,749
| -13% | -$566K | 0.01% | 313 |
|
|
2020
Q4 | $4.53M | Buy |
87,052
+20,778
| +31% | +$1.08M | 0.01% | 284 |
|
|
2020
Q3 | $1.77M | Sell |
66,274
-8,726
| -12% | -$233K | 0.01% | 312 |
|
|
2020
Q2 | $1.46M | Buy |
75,000
+34,000
| +83% | +$662K | ﹤0.01% | 325 |
|
|
2020
Q1 | $403K | Buy |
+41,000
| New | +$403K | ﹤0.01% | 369 |
|
|
2016
Q4 | – | Sell |
-70,000
| Closed | -$542K | – | 523 |
|
|
2016
Q3 | $542K | Buy |
70,000
+1,900
| +3% | +$14.7K | ﹤0.01% | 350 |
|
|
2016
Q2 | $413K | Hold |
68,100
| – | – | ﹤0.01% | 387 |
|
|
2016
Q1 | $580K | Sell |
68,100
-12,350
| -15% | -$105K | ﹤0.01% | 408 |
|
|
2015
Q4 | $960K | Hold |
80,450
| – | – | ﹤0.01% | 387 |
|
|
2015
Q3 | $811K | Hold |
80,450
| – | – | ﹤0.01% | 398 |
|
|
2015
Q2 | $1.34M | Buy |
80,450
+7,450
| +10% | +$124K | 0.01% | 410 |
|
|
2015
Q1 | $1.13M | Buy |
+73,000
| New | +$1.13M | 0.01% | 489 |
|